Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.
Faridi, Kamil F, Jordan B Strom, Harun Kundi, Neel M Butala, Jeptha P Curtis, Qi Gao, Yang Song, et al. 2023. “Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.”. Journal of the American Heart Association 12 (14): e029588.